5-Amino-1MQ vs Tirzepatide: Fat-Cell Enzyme vs Dual Incretin, the Evidence, Cost, and Combining Them

Every figure is an all-in monthly price covering the medication, physician review, refill management and shipping. There is no separate membership fee. GLP-1 prices are "from" prices because the vials are dose-specific and the price moves with the strength. Current pricing always lives on each product page.

This is the overlap that makes people compare the two, and it is worth separating what is human evidence from what is not.

Both stories point at fat tissue and insulin signalling, but tirzepatide's sits on top of an appetite mechanism and human trials, while 5-Amino-1MQ's has only been measured in mice.

The real difference is where the evidence lives

No study has compared them, and "which is stronger" has no answer. The meaningful difference is that every claim about tirzepatide on this page comes from people, and every claim about what 5-Amino-1MQ does comes from mice or cells. A physician reviewing an intake where weight is the main goal will usually look at a GLP-1 first.

Tirzepatide

Tirzepatide is the usual choice when appetite and total body weight are the problem, within the BMI ranges its trials enrolled: 30 or more, or 27 or more with a weight-related condition. It acts on two receptors, and in SURMOUNT-5 it produced more weight loss than semaglutide. Semaglutide vs tirzepatide covers that choice.

5-Amino-1MQ

5-Amino-1MQ suits someone whose interest is fat-cell metabolism or the NAD+ angle, with diet and activity already in place, who is not a GLP-1 candidate on weight grounds or wants a separate adjunct, and who accepts mouse-only evidence. Both of its main mouse studies paired it with a diet switch or exercise and reported the combination doing more than either alone.

They act through entirely different mechanisms, and some physicians prescribe them together. The honest picture:

• There is no human study of the combination, so no data on whether 5-Amino-1MQ adds anything to tirzepatide.
• They do not compete for a target. Tirzepatide acts on cell-surface receptors; 5-Amino-1MQ on an enzyme inside the cell.
• One theoretical interaction point. NNMT methylates some foreign compounds as well as nicotinamide, so blocking it could in principle change how some drugs are handled. Nothing specific is known about tirzepatide, which is a reason to list every medication on the intake.
• They are separate prescriptions. No Pepti product combines them. Never mix two vials in one syringe; tirzepatide stays once weekly, 5-Amino-1MQ once daily on weekdays.
• Starting on different dates makes it easier to tell which caused any change, especially in the early weeks of tirzepatide when nausea is most likely.

Your physician sets your directions after reviewing your intake and your full medication list. What peptides can you take with tirzepatide covers the common pairings.

The 503B proposal concerns outsourcing facilities and does not by itself change the 503A pathway for a named patient. The FDA has never published a safety-risk finding about 5-Amino-1MQ. Compounded medications are not FDA approved. Are peptides FDA approved explains the difference between not approved and not legal.

Both are injected under the skin (subcutaneously), rotating sites.

Tirzepatide. Once weekly. Every strength from 2.5 mg to 15 mg is a separate 2 mL vial drawn at 0.50 mL, which is 50 units on a U-100 insulin syringe, so when the dose changes the concentration changes and you keep drawing to the same line. Treatment starts at the lowest strength and steps up, typically at roughly four-week intervals as tolerance allows. The tirzepatide dosing chart lists every strength.

5-Amino-1MQ. 0.25 mL (25 units) once daily Monday through Friday, which is 0.25 mg from the 1 mg/mL vial. Twenty doses cover about four weeks. 5-Amino-1MQ dosage has the conversion table.

You do not need to calculate anything: your physician sets your directions after reviewing your intake, and your directions are printed on the vial. Both ship refrigerated with ice packs, with sterile syringes and alcohol prep pads, and refills run every 28 days, one vial per fill. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.

Tirzepatide. Nausea, diarrhoea, vomiting, constipation and reduced appetite are the most common, mostly during dose increases and usually easing. Less common but important: acute pancreatitis, gallbladder problems and dehydration. Low blood glucose is more likely with insulin or a sulfonylurea, and slower gastric emptying can change how oral medications, including oral contraceptives, are absorbed. The approved label carries a warning about thyroid C-cell tumours seen in rodents. Tirzepatide side effects covers them.

5-Amino-1MQ. There is no human safety database. The mouse studies reported no observable adverse effects at the doses used, and the 2024 work reported liver enzymes normalising in obese mice rather than rising, though neither was a toxicology study. Clinically, mostly injection-site redness, mild soreness or occasional bruising. 5-Amino-1MQ side effects has more.

For either, stop and contact your physician for any reaction that is severe, spreading or involves difficulty breathing, and for severe, persistent abdominal pain. For swelling of the face or throat or trouble breathing, call 911.

Tirzepatide has large randomised trials for weight management and type 2 diabetes, run on the branded product alongside diet and activity, and human data on its insulin-sensitivity effect. 5-Amino-1MQ has mouse and cell studies from essentially one research group, and the only human data is an observational study of its target enzyme. No trial has tested a compounded vial of either, or the two together. Anyone describing 5-Amino-1MQ as working like tirzepatide, or as adding to it, is going beyond what has been published. Best peptides for weight loss has the wider picture, and MOTS-c vs SLU-PP-332 vs 5-Amino-1MQ compares it with the other metabolic options.

Neither can be bought legitimately without a prescription. Sites selling them "for research use only" are not accountable for identity, purity, sterility or concentration. The prescription route:

1. Complete a free online intake covering your history, medications and what you want help with.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A pharmacy compounds it to that prescription. Lot test results are published at /quality/lab-results.
4. It ships refrigerated with your directions printed on the vial.
5. Your physician stays reachable for questions and dose changes.

Pepti is cash-pay and does not bill insurance. Step-by-step pages: how to get tirzepatide prescribed online and how to get 5-Amino-1MQ prescribed online.